MSAT Engineer
Abzena
MSAT Engineer
Abzena
CDMO for complex biologics and ADCs
The MSAT (Manufacturing Science and Technology) Department at Abzena provides technical leadership and supports technology transfer activities from Process Development to GMP Manufacturing. Additionally, MSAT is a key stakeholder for multiple secondary functions including support of Quality Systems, Process Improvements, Production Equipment Implementation, Process Automation, Data Management, etc.
We are seeking an experienced and highly skilled engineer with expertise in bioconjugation processes, including Antibody Drug Conjugates (ADCs) and Antibody Oligonucleotide Conjugates (AOCs), to support development-to-clinical cGMP manufacturing operations. You will serve as the MSAT technical bridge between process development and manufacturing, ensuring successful technology transfer, manufacturing readiness, and sustained process robustness for highly potent and complex biologic drug conjugates across the product lifecycle.
FLSA: Exempt
Abzena is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, and training.
This job description requires the handling, supervision, management, or otherwise exposure to RCRA hazardous waste as defined at 40 CFR (Code of Federal Regulations), parts 239 – 289.
Abzena is a contract development and manufacturing organization (CDMO) that provides integrated services for complex biologics and bioconjugates, including antibody-drug conjugates, from discovery through GMP manufacturing for clinical trials and commercial supply. Its offerings cover antibody discovery, protein engineering, cell line development, process and analytical development, and cGMP manufacturing, often using its proprietary ThioBridge and Composite Human Antibody platforms. Abzena differentiates itself by delivering end-to-end development and manufacturing for complex biologics and by leveraging its proprietary technologies, with global facilities in the US and UK and a history of strategic acquisitions. Its goal is to help biotech and pharma programs progress efficiently from research to commercial supply by providing integrated services and potential licensing opportunities.
Explore more opportunities at Abzena